ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,054Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 5176

$1.73M Total Retail Price of All Prescriptions

Rank: 79 out of 5176

670 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 670 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 670 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 22,097 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 1,212 1,027 1 1
AMLODIPINE BESYLATE 1,208 1,029 2 2
OMEPRAZOLE 863 684 3 3
METOPROLOL TARTRATE 858 802 4 6
METFORMIN HCL 695 566 5 7
AMLODIPINE BESYLATE-BENAZEPRIL 591 473 10 6 55
FUROSEMIDE 520 469 7 8
HYDROCHLOROTHIAZIDE 502 400 8 10
ATORVASTATIN CALCIUM 476 328 9 9
GABAPENTIN 465 337 10 21
ENALAPRIL MALEATE 461 398 11 22
SINGULAIR 448 332 12 62
LISINOPRIL 433 373 13 5
HYDRALAZINE HCL 421 368 14 73
ZOLPIDEM TARTRATE 387 256 15 17
CLOPIDOGREL 379 335 16 26
LEVOTHYROXINE SODIUM 378 320 17 4
CARVEDILOL 372 336 18 24
LOSARTAN POTASSIUM 368 329 19 14
MIRTAZAPINE 330 288 20 45
PLAVIX 326 290 21 29
ADVAIR DISKUS 315 223 22 32
RANITIDINE HCL 314 280 23 36
JANUVIA 310 280 24 25
PROAIR HFA 310 231 24 60
DIOVAN HCT 305 258 26 39
WARFARIN SODIUM 304 286 27 13
METOPROLOL SUCCINATE 288 257 28 11
TRAMADOL HCL 279 225 29 40
CRESTOR 278 232 30 15
IBUPROFEN 270 168 31 72
LOSARTAN-HYDROCHLOROTHIAZIDE 269 219 32 35
VENTOLIN HFA 234 182 33 64
ALENDRONATE SODIUM 233 217 34 18
NIFEDIPINE ER 231 202 35 48
DONEPEZIL HCL 224 215 36 28
AMMONIUM LACTATE 203 185 37 91
SERTRALINE HCL 201 150 38 30
TAMSULOSIN HCL 197 194 39 20
NEXIUM 194 139 40 16
MONTELUKAST SODIUM 192 137 41 123
JANUMET 170 134 42 77
NAMENDA 167 167 43 47
SPIRIVA 166 152 44 54
EVISTA 157 135 45 65
DIOVAN 157 140 45 19
ATENOLOL 154 143 47 12
BYSTOLIC 152 137 48 96
TRAZODONE HCL 143 111 49 71
NAPROXEN 140 106 50 95
LANTUS SOLOSTAR 134 99 51 70
DICLOFENAC SODIUM 130 83 52 160
ACETAMINOPHEN-CODEINE 128 112 S3 53 127
PROVENTIL HFA 127 83 54 226
GLIPIZIDE 125 98 55 63
ALCOHOL PREP PADS 118 99 56 198
TRAMADOL HCL-ACETAMINOPHEN 117 89 57 116
CITALOPRAM HBR 114 81 58 31
CLOTRIMAZOLE-BETAMETHASONE 112 90 59 94
LEVEMIR FLEXPEN 111 101 60 200
ISOSORBIDE MONONITRATE ER 111 103 60 44
ALLOPURINOL 110 98 62 41
OXYCODONE-ACETAMINOPHEN 109 58 S2 63 101
FLUTICASONE PROPIONATE 108 74 64 38
LYRICA 104 79 65 133
LIPITOR 102 86 66 51
FENOFIBRATE 102 78 66 102
PREDNISONE 101 74 68 52
BENAZEPRIL HCL 101 76 68 131
PAROXETINE HCL 100 65 70 93
AZITHROMYCIN 99 58 71 42
NOVOLOG FLEXPEN 98 89 72 196
HYDROCODONE-ACETAMINOPHEN 95 40 S3 73 27
PRADAXA 93 83 74 192
MELOXICAM 83 65 75 53
PEN NEEDLE 82 69 76 144
LACTULOSE 78 73 77 87
MEGESTROL ACETATE 76 75 R 78 263
CLOBETASOL PROPIONATE 75 62 79 130
SYMBICORT 75 68 79 120
MEGACE ES 74 71 R 81 423
CIPROFLOXACIN HCL 71 55 82 84
AMOX TR-POTASSIUM CLAVULANATE 70 51 83 141
GLYBURIDE-METFORMIN HCL 70 54 R 83 76
LANSOPRAZOLE 69 51 85 113
DILTIAZEM HCL 69 69 85 316
GLYBURIDE 68 65 R 87 67
NASONEX 65 51 88 178
ACTONEL 64 60 89 134
GEMFIBROZIL 64 29 89 139
TRICOR 62 47 91 148
AVODART 61 61 92 107
SANTYL 60 55 93 124
FINASTERIDE 58 53 94 69
DIGOXIN 57 57 95 56
CARBIDOPA-LEVODOPA 57 53 95 98
LANTUS 57 53 95 66
SOLARAZE 57 55 95 157
TIZANIDINE HCL 56 31 99 326
KETOCONAZOLE 55 51 100 233
LACLOTION 55 52 100 299
BENAZEPRIL-HYDROCHLOROTHIAZIDE 54 39 102 312
MECLIZINE HCL 52 52 103 81
CYCLOBENZAPRINE HCL 51 16 R 104 143
NOVOFINE 51 41 104 550
VALSARTAN-HYDROCHLOROTHIAZIDE 50 37 106 292
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.